Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Current assets    
Cash and cash equivalents $ 33,605 $ 75,558
Accounts receivable, net 191,015 178,189
Prepaid expenses 7,704 8,589
Other current assets 10,017 3,730
Total current assets 242,341 266,066
Property and equipment, net 45,782 39,327
Right-of-use assets 9,127 10,073
Intangible assets, net 313,505 379,632
Goodwill 220,072 561,576
Other non-current assets 34,713 9,882
TOTAL ASSETS 865,540 1,266,556
Current liabilities    
Accounts payable 159,200 119,338
Accrued revenue share 33,934 69,221
Accrued compensation 7,209 10,984
Other current liabilities 35,681 21,377
Total current liabilities 236,024 220,920
Long-term debt, net of debt issuance costs 383,490 410,522
Deferred tax liabilities, net 20,424 13,940
Other non-current liabilities 11,670 13,919
Total liabilities 651,608 659,301
Commitments and contingencies (Note 15)
Stockholders’ equity    
Preferred stock 100 100
Common stock 10 10
Additional paid-in capital 858,191 822,217
Treasury stock (758,125 shares at March 31, 2024, and March 31, 2023) (71) (71)
Accumulated other comprehensive loss (48,955) (41,945)
Accumulated deficit (595,343) (175,115)
Total stockholders’ equity 213,932 605,196
Non-controlling interest 0 2,059
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 865,540 $ 1,266,556